68 results
Page 2 of 4
10-K/A
EX-31.1
zkm5r0rb9cbiw4dcuxdy
9 Nov 23
Annual report (amended)
4:05pm
10-K/A
EX-31.2
xqfg565nxu87spoa56cv
9 Nov 23
Annual report (amended)
4:05pm
8-K
EX-10.1
hpawlm73h37oci
5 Sep 23
Xilio Therapeutics Announces Promotion of Katarina Luptakova, M.D., to Chief Medical Officer and Scott Coleman, Ph.D., to Chief Development Officer
8:35am
8-K
EX-10.1
4tud267cwn0glbldg
3 Aug 23
Departure of Directors or Certain Officers
4:15pm
S-3
EX-1.2
97zetqstx 41
9 Nov 22
Shelf registration
4:15pm
8-K
EX-10.1
2lkiqvh94m75vyu4z
16 Jun 22
Departure of Directors or Certain Officers
7:45am